Robert L. Findling, M.D.
Dr. Findling is the Director of the Division of Child
and Adolescent Psychiatry at University Hospitals of Cleveland. He is also a Professor
of Psychiatry and Pediatrics at Case Western Reserve University. Dr. Findling earned
his undergraduate degree at Johns Hopkins University and went to medical school
at the Medical College of Virginia. Dr. Findling did a joint residency-training
program in Pediatrics, Psychiatry, and Child & Adolescent Psychiatry at Mt. Sinai
Hospital in New York City. He is board certified in all three specialties.
Dr. Findling’s research endeavors have focused on pediatric psychopharmacology and
psychotic disorders in the young. He has extensive experience in pharmacokinetic
studies of psychotropic agents in pediatric patients. Dr. Findling has been honored
with numerous awards and has received international recognition as a clinical investigator.
Dr. Findling’s research is also supported in part by the American Foundation for
Suicide Prevention, the St. Luke’s Foundation of Cleveland, Ohio and the pharmaceutical
industry. In addition, Dr. Findling is a member of the American Academy of Child
and Adolescent Psychiatry’s (AACAP) Work Group on Research.
Jaswinder K. Ghuman, M.D.
Dr. Jaswinder Ghuman is the Director of the Infant and Preschool Program in the
Division of Child and Adolescent Psychiatry at the University of Arizona. She is
board certified both in general psychiatry and child and adolescent psychiatry.
In addition to conducting research, she provides clinical services to preschool
children with developmental and psychiatric disorders
Dr. Jaswinder Ghuman received her MB, BS (MD) degree in 1973 from the Christian
Medical College, Punjab University, India, and completed her general psychiatry
training at Rochester Psychiatric Center and Washington University, St. Louis, MO,
USA. She received her Child and Adolescent Psychiatry Fellowship training at the
Johns Hopkins University, and developed and directed the Infant and Preschool Clinic
at the Kennedy Krieger Institute, Johns Hopkins University. She was appointed by
the Governor to the Maryland Advisory Council on Attention Deficit Hyperactivity
Disorder.
Dr. Ghuman received an NIMH sponsored Minority Supplement grant and developed a
parent and teacher questionnaire, Ghuman-Folstein Screen for Social Interaction,
to screen for social interaction in 6 months to 5-year-old children with autism,
pervasive developmental disorders (PDD), and other developmental disorders. Dr.
Ghuman was co-investigator in the multisite risperidal, methylphenidate and guanfacine
studies in children and adolescents with PDD for the NIMH sponsored Autism RUPP
Network. She was also co-principal investigator in the NIMH sponsored multisite
Preschool ADHD Treatment Study.
Dr. Scott H. Kollins
Dr. Scott H. Kollins received his undergraduate degree in psychology from Duke University
and his Masters and Doctoral degrees in clinical psychology from Auburn University.
He completed his internship at the University of Mississippi Medical Center and
served on the faculty in the Psychology Department at Western Michigan University
for three years. Dr. Kollins joined the faculty at the Duke University Medical Center
in 2000, where he is currently an Associate Professor in the Department of Psychiatry
and Behavioral Science, and the Director of the Duke ADHD Program. His research
has focused on stimulant psychopharmacology, the genetics of ADHD, and the intersection
between ADHD and substance abuse. Dr. Kollins has been consistently funded by a
number of different federal and industry sources, and has published over 30 papers
in peer-reviewed journals. He is a member of both the College on Problems of Drug
Dependence and the American College of Neuropsychopharmacology. He has served on
numerous federal committees and has reviewed manuscripts for over 20 different journals.
Dr. Kollins is also a licensed clinical psychologist and maintains an active practice.
